| scholarly article | Q13442814 |
| P2093 | author name string | Kozma SC | |
| Bos JL | |||
| Hynes NE | |||
| Groner B | |||
| Buser K | |||
| Bogaard ME | |||
| Saurer SM | |||
| P2860 | cites work | Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 |
| Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 | ||
| Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter | Q29614259 | ||
| Breast tumor cell lines from pleural effusions | Q34209613 | ||
| Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. | Q34708404 | ||
| Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects | Q35590255 | ||
| Analysis of the transforming potential of the human H-ras gene by random mutagenesis | Q36264166 | ||
| New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line | Q36885249 | ||
| New Human Transforming Genes Detected by a Tumorigenicity Assay | Q36947151 | ||
| A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient | Q37565544 | ||
| Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia | Q38352393 | ||
| The molecular genetics of cellular oncogenes | Q40201361 | ||
| A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene | Q40560010 | ||
| Biological properties of human c-Ha-ras1 genes mutated at codon 12. | Q42817584 | ||
| New Method for Detecting Cellular Transforming Genes | Q42824470 | ||
| The oncogenic activation of human p21ras by a novel mechanism | Q44418236 | ||
| Characterization of a human colon/lung carcinoma oncogene | Q59086201 | ||
| A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides | Q69022841 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | 5963-5971 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. | |
| P478 | volume | 15 |
| Q39979475 | A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition. |
| Q40070223 | A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells |
| Q42831336 | A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo |
| Q42803597 | Activation of c-Ki-ras coexists with c-myc amplification in cells from a nude mouse tumor induced by the human breast carcinoma cell line SW 613-S. |
| Q24564358 | Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences |
| Q40341063 | Anandamide inhibits adhesion and migration of breast cancer cells |
| Q58605496 | Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction |
| Q21195230 | Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation |
| Q37141501 | Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. |
| Q30431290 | CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness |
| Q47123785 | Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems |
| Q70267772 | Conformational effects of the substitution of Arg for Gly 13 in the ras oncogene-encoded P21 protein |
| Q37284069 | Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway |
| Q24303568 | DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth |
| Q34769614 | Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells |
| Q39281631 | Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation |
| Q30575256 | E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines |
| Q37042957 | Early and Late Events in the Development of Human Breast Cancer |
| Q33893378 | Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells |
| Q38997782 | Evidence for aldosterone-dependent growth of renal cell carcinoma |
| Q33549613 | Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. |
| Q33686865 | Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells |
| Q34066386 | GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines |
| Q25257668 | HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells |
| Q37420053 | High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors |
| Q37380664 | Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells |
| Q43744383 | Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. |
| Q41727247 | IGF-independent regulation of breast cancer growth by IGF binding proteins |
| Q37114859 | Igf1r as a therapeutic target in a mouse model of basal-like breast cancer |
| Q55176494 | Infrequent ras mutation in human stomach cancers. |
| Q91474380 | Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation |
| Q37213805 | Integrated analysis of breast cancer cell lines reveals unique signaling pathways |
| Q33320695 | K-ras mutations in sinonasal cancers in relation to wood dust exposure |
| Q36482942 | Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer |
| Q34087168 | Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells |
| Q36070110 | Mispair formation in DNA can involve rare tautomeric forms in the template |
| Q23912247 | Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride |
| Q33825046 | Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function |
| Q35770590 | Next-generation sequencing reveals the biological significance of the N(2),3-ethenoguanine lesion in vivo |
| Q36081804 | Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators |
| Q37446199 | Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway |
| Q72452835 | Raf-1 protein expression in human breast cancer cells |
| Q40658383 | Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis |
| Q34407524 | Ribosome-induced tuning of GTP hydrolysis by a translational GTPase |
| Q52007365 | Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. |
| Q36686648 | Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype |
| Q34352727 | TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells |
| Q35973719 | Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription |
| Q33823577 | Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells. |
| Q37427689 | The EGF receptor system as a target for antitumor therapy |
| Q40456230 | The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300. |
| Q37041619 | The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells |
| Q38206214 | The polymerase chain reaction: an improved method for the analysis of nucleic acids |
| Q37649657 | The proto-oncogene KRAS is targeted by miR-200c |
| Q34316122 | The ras signaling pathway in mammary tumorigenesis and metastasis. |
| Q36486913 | The role of ras gene expression and transforming growth factor α production in the etiology and progression of rodent and human breast cancer |
| Q74377212 | The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer |
| Q54331857 | Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells. |
| Q36766981 | Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues |
| Q40990697 | p53 Trans-Dominantly Suppresses Tumor Formation of Human Breast Cancer Cells Mediated by Retroviral Bulk Infection without Marker Gene Selection: An Expeditious In Vitro Protocol with Implications towards Gene Therapy |
Search more.